Effects of artificial colloids on haemostasis

British Journal of Hospital Medicine

Volumn 70, Issue 2, 2009, Pages 101-103

  Yu, Bu Wei ^a   Jin, Shan Liang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64549132548     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2009.70.2.38909     Document Type: Review

References (38)

1. Boldt J, Knothe C, Zickmann B et al (1993) Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 76: 1185-90
2. Brodin B, Hesselvik F, von-Schenck H (1984) Decrease of plasma fibronectin concentration following infusion of a gelatin based plasma substitute in man. Scand J Clin Lab Invest 44: 529-33
3. Chong Sung K, Kum Suk P, Mi Ja Y et al (2006) Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand 50: 108-11
4. Collins PW, MacchiaveUo LI, Lewis SJ et al (2006) Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 135: 220-7
5. Deusch E, Gamsjager T, Kress HG et al (2003) Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 97: 680-3
6. Egli GA, Zollinger A, Seifert B et al (1997) Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 78: 684-9
7. Engvall E, RuoSlahti E, Miller VJ (1978) Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 147:1584-95
8. Evans PA, Glenn JR, Heptinstall S et al (1998) Effects of gelatin based resuscitation fluids on platelet aggregation. Br J Anaesth 81: 198-202
9. Evans PA, Heptinstall S, Crowhurst EC et al (2003) Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. J Thromb Haemost 1: 2140-8
10. Franz A, Braunlich P, Gamsjager T et al (2001) The effects of hydroxyethyl starches of varying molecular weight on platelet function. Anesth Analg 92: 1402-7
11. Fries D, Innerhofer P, Klingler A et al (2002) The effect of the combined administration of colloids and lactated ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis. Anesth Analg 94: 1280-7
12. Fries D, Krismer A, Klingler A et al (2005) Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 95: 172-7
13. Funk W, Baldinger V (1995) Microcirculatory perfusion during volume therapy. A comparative study using crystalloid or colloid in awake animals. Anesthesiology 82: 975-82
14. Gallandat Huet RC, Siemons A, Baus D et al (2000) A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 47: 1207-15
15. Haisch G, Boldt J, Krebs C et al (2001) The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 91: 565-71
16. Jamnicki M, Zollinger A, Seifert B et al (1998) Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 87: 989-93
17. Karoutsos S, Nathan N, Lahrimi A et al (1999) Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 82: 175-7
18. Kasper SM, Meinert P, Kampe S et al (2003) Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99: 42-7
19. Langeron O, Doelberg M, Ang ET et al (2001) Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92: 855-62
20. Lucas CE, Denis R, Ledgerwood AM et al (1988) The effects of Hespan on serum and lymphatic albumin, globulin, and coagulant protein. Ann Surg 207: 416-20
21. Mardel SN, Saunders FM, Allen H et al (1998) Reduced quality of clot formation with gelatin based plasma substitutes. BrJ Anaesth 80: 204-7
22. Monroe DM, Hoffman M, Roberts HR (2002) Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22: 1381-9
23. Nielsen VG (2005) Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 49: 1163-71
24. Nielsen VG (2006a) Effects of hextend hemodilu'tion on plasma coagulation kinetics in the rabbit: role of factor XIII-mediated fibrin polymer crosslinking. J Surg Res 132: 17-22
25. Nielsen VG (2006b) Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. J Heart Lung Transplant 25: 1344-52
26. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI et al (2006) Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 102: 998-1006
27. Petroianu GA, Liu J, Maleck WH et al (2000) The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch or Ringer's solution on thrombelastograph. Anesth Analg 90: 795-800
28. Stoelting RK (1991) Blood substitutes. In: Stoelting RK, ed. Pharmacology and Physiology in Anesthetic Practice. 2nd edn. JB Lippincott, Philadelphia: 577-9
29. Stump DC, Strauss RG, Henriksen RA et al (1985) Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 25: 349-54
30. Tabuchi N, de Haan J, Gallandat Huet RC et al (1995) Gelatin use impairs platelet adhe-sion during cardiac surgery. Thromb Haemost 74: 1447-51
31. Thaler U, Deusch E, Kozek-Langenecker SA (2005) In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions. Anaesthesia 60: 554-9
32. Treib J, Haass A, Pindur G et al (1995) HES 200/0.5 is not HES 200/0.5: Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 74: 1452-6
33. Treib J, Haass A, Pindur G et al (1996) All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 36: 450-5
34. Van der Linden P, Schmartz D (1992) Pharmacology of gelatins. In: Baron JF, ed. Plasma Volume Expansion. Arnette, Paris: 67-74
35. Van der Linden PJ, De Hert SG, Deraedt D et al (2005) Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 101: 629-34
36. Veldman A, Fischer D (2004) Is hydroxyethyl starch safe in neonates? Pediatr Crit Care Med 5: 202-3
37. Wiedermann CJ (2004) Hydroxyethyl starch - can the safety problems be ignored? Wien Klin Wochenschr 116: 583-94
38. Wilkes MM, Navickis RJ, Sibbald WJ (2001) Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a metaanalysis of postoperative bleeding. Ann Thorac Surg 72: 527-33; discussion 534